NCT04512963 - Phase I Study of Progerinin in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

July 27, 2021

Study Completion Date

July 27, 2021

Conditions

Hutchinson-Gilford Progeria SyndromeWerner Syndrome

Interventions

DRUG

Progerinin

100 mg/g nano-suspension for oral use

DRUG

Placebo

A substance that has no therapeutic effect, used as a control in testing Progerinin

Trial Locations (1)

PRG S&T Investigational Site, Glendale